{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreichg3b4mip7haymvmyvhee7w6doljpihauok3yioukhejdpqfjhuu",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mmgyp2stczc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigwaiqjf7nahwke5aswbihiyc622zjaplyzjnfmadmwxya5z65aim"
    },
    "mimeType": "image/webp",
    "size": 78844
  },
  "path": "/releases/2026/05/260521072408.htm",
  "publishedAt": "2026-05-22T02:12:43.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.",
  "title": "Popular weight loss drugs like Wegovy may also target arthritis inflammation"
}